RCAMU
Rothschild & Co Asset Management US’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.76M | Buy |
245,658
+38,230
| +18% | +$429K | 0.04% | 215 |
|
|
2022
Q3 | $2.3M | Buy |
207,428
+7,005
| +3% | +$77.6K | 0.04% | 223 |
|
|
2022
Q2 | $1.69M | Sell |
200,423
-6,184
| -3% | -$52.2K | 0.03% | 239 |
|
|
2022
Q1 | $2.81M | Sell |
206,607
-37,832
| -15% | -$515K | 0.04% | 230 |
|
|
2021
Q4 | $4.81M | Buy |
244,439
+72,933
| +43% | +$1.43M | 0.06% | 219 |
|
|
2021
Q3 | $5.51M | Buy |
171,506
+130
| +0.1% | +$4.17K | 0.07% | 211 |
|
|
2021
Q2 | $5.8M | Buy |
+171,376
| New | +$5.8M | 0.07% | 214 |
|